In vivo chemical inhibition of TRPV4 in cultured diabetic rat CF, with the antagonist HC067047, reduced expression of markers of MF differentiation and attenuated increases in TGF-β1 levels, while also reducing phosphorylation of Smad3 [183]. Here, TGFB1 is linked to cystic fibrosis.